Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9ELX

Crystal Structure of human cyclic GMP-AMP synthase (cGAS) in complex with compound 5; 3-((2-((3-chloro-4-fluorophenyl)amino)-2-oxoethyl)carbamoyl)picolinic acid

This is a non-PDB format compatible entry.
Summary for 9ELX
Entry DOI10.2210/pdb9elx/pdb
DescriptorCyclic GMP-AMP synthase, PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER, 3-{[2-(3-chloro-4-fluoroanilino)-2-oxoethyl]carbamoyl}pyridine-2-carboxylic acid, ... (6 entities in total)
Functional Keywordshuman cyclic gmp-amp synthase, amp-pnp compound 5, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight43833.37
Authors
Sietsema, D.V. (deposition date: 2024-12-05, release date: 2025-01-01)
Primary citationCyr, P.,Fader, L.D.,Burch, J.D.,Pike, K.A.,Sietsema, D.V.,Boily, M.O.,Ciblat, S.,Sgarioto, N.,Skeldon, A.M.,Gaudreault, S.,Le Gros, P.,Dumais, V.,McKay, D.J.J.,Abraham, N.S.,Seliniotakis, R.,Beveridge, R.E.
Discovery of Potent and Orally Bioavailable Pyrimidine Amide cGAS Inhibitors via Structure-Guided Hybridization.
Acs Med.Chem.Lett., 15:2201-2209, 2024
Cited by
PubMed Abstract: Using a high-throughput screening (HTS) approach, a new GTP-site binding pyridine-carboxylate series of cGAS inhibitors was discovered. The biochemical potency of this new pyridine carboxylate series was improved 166-fold from the original hit to double-digit nanomolar levels using structure-based design insights, but the series was found to suffer from low permeability and low bioavailability. A structure-based hybridization of the metal-binding motifs of the pyridine carboxylate series and our previously disclosed tetrahydrocarboline GTP-site ligand identified pyrimidine amide compound . Compound is potent against both human and mouse cGAS isoforms and has a favorable pharmacokinetic (PK) profile in mice. Additionally, compound displayed a dose-dependent reduction in cGAMP production in a ConA pharmacodynamic mouse model of acute liver injury, demonstrating potential utility as an in vivo tool compound for further investigation of the cGAS pathway.
PubMed: 39691514
DOI: 10.1021/acsmedchemlett.4c00471
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.53 Å)
Structure validation

231029

건을2025-02-05부터공개중

PDB statisticsPDBj update infoContact PDBjnumon